Aurobindo Pharma fundamental analysis

AUROPHARMA

1296.5

15.40 (-1.17%)
Last updated on 13 Mar, 2026 | 15:56 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aurobindo Pharma Fundamentals

P/E Ratio

21.87

P/B Ratio

2.12

Div. Yield

0

Sector P/E

60.72

Sector P/B

2.7

Sec. Div. Yield

0.58

Aurobindo Pharma Fundamentals is currently trading with a P/E Ratio of 21.87, compared to the sector average of 60.72. Its P/B Ratio stands at 2.12, while the sector’s is 2.7. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.58%.

Aurobindo Pharma Score Card

  • price_icon
    Price

    Expensive

  • chart_icon
    Growth

    Poor

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Average

On its scorecard, Aurobindo Pharma reflects: Price – Expensive, Growth – Poor, Quality – Good, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost